<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Eshaghi G</submitter><funding>Friedrich-Schiller-Universität Jena</funding><pubmed_abstract>Here we report a novel platform for the detection of nucleocapsid (N) and receptor-binding domain (RBD) of spike (S) proteins of SARS-CoV-2 viruses using the surface plasmon resonance (SPR) technique. We demonstrate that the functionalization of SPR sensors with molecular 2D materials - 1 nm thick carbon nanomembranes (CNMs) significantly enhances sensitivity. CNMs terminated with azide linker (N3-CNM) enable covalent bonding of SARS-CoV-2 antibodies for specific immobilization of the N- and S-proteins to the sensor surface. The successful and stable hierarchical functionalization is confirmed by multiparametric SPR measurements complemented with X-ray photoelectron spectroscopy and polarization modulation infrared reflection absorption spectroscopy. The obtained equilibrium dissociation constants (KD) for the N-protein and the S-protein in the physiological buffer are 570 ± 50 pM and 22 ± 2 pM and the low detection limits (LODs) are ~ 190 pM and ~ 10 pM, respectively. The high specificity of the developed sensors is shown via their negligible cross-reactivity with SARS-CoV-1 and MERS-CoV proteins. Finally, detection of SARS-CoV-2 proteins in nasopharyngeal swab samples with the LOD of ~ 40 pM is demonstrated. The proposed methodology enables the development of biosensors that cover clinically relevant range for the direct and immediate detection of SARS-CoV-2 without any amplification or labeling.</pubmed_abstract><journal>Scientific reports</journal><pagination>31248</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12378216</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Highly sensitive and label-free detection of SARS-CoV-2 proteins via surface plasmon resonance using biofunctionalization with 1 nm thick carbon nanomembranes.</pubmed_title><pmcid>PMC12378216</pmcid><pubmed_authors>Neumann C</pubmed_authors><pubmed_authors>Gary D</pubmed_authors><pubmed_authors>Fischer T</pubmed_authors><pubmed_authors>Kaiser D</pubmed_authors><pubmed_authors>Frey M</pubmed_authors><pubmed_authors>Ennaciri R</pubmed_authors><pubmed_authors>Frankenfeld K</pubmed_authors><pubmed_authors>Eshaghi G</pubmed_authors><pubmed_authors>Rasouli HR</pubmed_authors><pubmed_authors>Turchanin A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Highly sensitive and label-free detection of SARS-CoV-2 proteins via surface plasmon resonance using biofunctionalization with 1 nm thick carbon nanomembranes.</name><description>Here we report a novel platform for the detection of nucleocapsid (N) and receptor-binding domain (RBD) of spike (S) proteins of SARS-CoV-2 viruses using the surface plasmon resonance (SPR) technique. We demonstrate that the functionalization of SPR sensors with molecular 2D materials - 1 nm thick carbon nanomembranes (CNMs) significantly enhances sensitivity. CNMs terminated with azide linker (N3-CNM) enable covalent bonding of SARS-CoV-2 antibodies for specific immobilization of the N- and S-proteins to the sensor surface. The successful and stable hierarchical functionalization is confirmed by multiparametric SPR measurements complemented with X-ray photoelectron spectroscopy and polarization modulation infrared reflection absorption spectroscopy. The obtained equilibrium dissociation constants (KD) for the N-protein and the S-protein in the physiological buffer are 570 ± 50 pM and 22 ± 2 pM and the low detection limits (LODs) are ~ 190 pM and ~ 10 pM, respectively. The high specificity of the developed sensors is shown via their negligible cross-reactivity with SARS-CoV-1 and MERS-CoV proteins. Finally, detection of SARS-CoV-2 proteins in nasopharyngeal swab samples with the LOD of ~ 40 pM is demonstrated. The proposed methodology enables the development of biosensors that cover clinically relevant range for the direct and immediate detection of SARS-CoV-2 without any amplification or labeling.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-05-10T04:22:22.515Z</modification><creation>2026-04-08T01:29:25.329Z</creation></dates><accession>S-EPMC12378216</accession><cross_references><pubmed>40855107</pubmed><doi>10.1038/s41598-025-16342-5</doi></cross_references></HashMap>